Multiple studies in breast, ovarian, and lung cancer provide convincing evidence for the role of PAR1 in regulating blood vessel formation and expression of angiogentic factors such as VEGF, IL-8, and GRO-α [2,5,7]. This evidence concerns the gene F2R and lung cancer.